Cargando...
BRM270 Suppresses Cervical Cancer Stem Cell Characteristics and Progression by Inhibiting SOX2
Background/Aim: Cervical cancer is one of the leading causes of cancer death in women worldwide. BRM270 (BRMLife) has therapeutic potential for cancer treatment owing to its ability to inhibit cell proliferation, and expression of cluster of differentiation (CD) 133 in CD133(+) cancer cells. This st...
Guardado en:
| Publicado en: | In Vivo |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
International Institute of Anticancer Research
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7279830/ https://ncbi.nlm.nih.gov/pubmed/32354896 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11879 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|